Regen BioPharma Inc (OTCPK:RGBPP.PFD)
$ 1.7 0.0125 (0.74%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Regen BioPharma Inc At Emerging Growth Conference Transcript

Jan 25, 2023 / 08:30PM GMT
Release Date Price: $34.5 (+10.58%)
Ana Berry
Berry Media, Inc. - Moderator

Welcome back, everyone. Next up, we have Regen BioPharma Inc. It trades on the OTC pink sheets under the symbol RGBP and RGBPP. And as a publicly traded biotechnology company focused on the immunology and immunotherapy space, rapidly advancing novel technologies through preclinical and Phase 1 and 2 clinical trials and small molecule therapies for treating cancer and autoimmune disorders. Please welcome the President and CEO, David Koos, as well as Senior Scientific Consultant, Harry Lander. Welcome back, gentlemen.

David Koos
Regen BioPharma, Inc. - CEO & Chairman

Hello, good morning. I guess it's good afternoon back there.

Ana Berry
Berry Media, Inc. - Moderator

People are all over the world

David Koos
Regen BioPharma, Inc. - CEO & Chairman

Yes.

Ana Berry;David Koos
Berry Media, Inc. - Moderator;Regen

So you can get all three if you need.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot